66
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

“Barriers and Advantages of Self-Sampling Tests, for HPV Diagnosis: A Qualitative Field Experience Before Implementation in a Rural Community in Ecuador”

ORCID Icon, ORCID Icon, , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 947-960 | Received 15 Dec 2023, Accepted 10 May 2024, Published online: 30 May 2024

References

  • Buskwofie A, David-West G, Clare CA. A review of cervical cancer: incidence and disparities. J Nat Med Associa. 2020;112(2):229–232. doi:10.1016/j.jnma.2020.03.002
  • Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
  • Perehudoff K, Vermandere H, Williams A, et al. Universal cervical cancer control through a right to health lens: refocusing national policy and programmes on underserved women. BMC Int Health Hum Rights. 2020;20(1):21. doi:10.1186/s12914-020-00237-9
  • World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. World Health Organization; 2020. Available from: https://www.who.int/publications/i/item/9789240014107. Accessed May 24, 2024.
  • International Agency for Research in Cance. International agency for research in cancer. Ecuador fact sheets 2020. IARC; 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/218-ecuador-fact-sheets.pdf. Accessed May 24, 2024.
  • Bruni L, Albero G, Serrano B, et al. Human papillomavirus and related diseases report Ecuador. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2019. Available from: https://hpvcentre.net/statistics/reports/ECU.pdf. Accessed May 24, 2024.
  • Vega B, Sacoto C Prevalencia de cáncer de cuello uterino en el Ecuador y estrategias para su reducción. Facultad de Ciencias Médicas Universidad de Cuenca; 2012. Available from: https://dspace.ucuenca.edu.ec/bitstream/123456789/20387/1/Bernardo%20Vega%20C.%20y%20Catalina%20Sacoto.pdf. Accessed May 24, 2024.
  • Ministerio de Salud Pública del Ecuador M. Estrategia Nacional para la prevención del Cáncer en el Ecuador 2017. MSP; 2017. Available from: https://aplicaciones.msp.gob.ec/salud/archivosdigitales/documentosDirecciones/dnn/archivos/ac_0059_2017.pdf. Accessed May 24, 2024.
  • Ministerio de Salud Pública del Ecuador M. Plan Nacional de salud sexual y salud repoductiva 2017–2021. MSP; 2017. Available from: https://ecuador.unfpa.org/sites/default/files/pub-pdf/PLAN%20NACIONAL%20DE%20SS%20Y%20SR%202017-2021.pdf. Accessed May 24, 2024.
  • Ministerio de Salud Pública del Ecuador M. Esquema de vacunación Ecuador; 2019. Available from: https://www.salud.gob.ec/wp-content/uploads/2020/01/ESQUEMA-DE-VACUNACIO%CC%81N.DIC_.2019.ok_.pdf. Accessed May 24, 2024.
  • de Salud Pública Del Ecuador M M. Protocolos con evidencia para la detección oportuna del cáncer de cuello uterino; 2015. Available from: https://webcache.googleusercontent.com/search?q=cache:FxdiESuIbPYJ:https://aplicaciones.msp.gob.ec/salud/archivosdigitales/sigobito/tareas_seguimiento/1614/protocolos_cancer_c%25C3%2589rvico_uterino._13_revision__borrador.-1.doc+&cd=1&hl=es&ct=clnk&gl=ec. Accessed May 24, 2024.
  • Instituto Nacional de Estadísticas y Censos. Encuesta Nacional de Salud y Nutrición. INEC; 2018. Available from: https://www.ecuadorencifras.gob.ec/documentos/web-inec/Estadisticas_Sociales/ENSANUT/ENSANUT_2018/Principales%20resultados%20ENSANUT_2018.pdf. Accessed May 24, 2024.
  • Agurto I, Bishop A, Sánchez G, Betancourt Z, Robles S. Perceived barriers and benefits to cervical cancer screening in Latin America. Preventive Med. 2004;39(1):91–98. doi:10.1016/j.ypmed.2004.03.040
  • Zorogastua K, Erwin D, Thelemaque L, Pulley L, Jandorf L. Intrinsic factors of non-adherence to breast and cervical cancer screenings among latinas. J Racial Ethnic Health Disparit. 2016;3(4):658–666. doi:10.1007/s40615-015-0184-x
  • Vega Crespo B, Neira VA, Ortíz Segarra J, et al. Barriers and facilitators to cervical cancer screening among under-screened women in Cuenca, Ecuador: the perspectives of women and health professionals. BMC Public Health. 2022;22(1):2144. doi:10.1186/s12889-022-14601-y
  • Bautista-Valarezo E, Vega Crespo B, Maldonado-Rengel R, Espinosa M, Neira V, Verhoeven V. Knowledge and perceptions about cervical cancer and HPV screening in women in rural areas of Ecuador: a qualitative research study. IJERPH. 2022;19(17):11053. doi:10.3390/ijerph191711053
  • World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention. Geneva: World Health Organization; 2021. Available from: https://apps.who.int/iris/handle/10665/342365. Accessed May 24, 2024.
  • Giannini A, Di Donato V, Sopracordevole F, et al. Outcomes of high-grade cervical dysplasia with positive margins and HPV persistence after cervical conization. Vaccines. 2023;11(3):698. doi:10.3390/vaccines11030698
  • Baezconde-Garbanati L, Agurto I, Gravitt PE, et al. Barriers and innovative interventions for early detection of cervical cancer. Salud Publica Mex. 2019;61(4):456. doi:10.21149/10425
  • Kang M, Ha SY, Cho HY, et al. Comparison of papanicolaou smear and human papillomavirus (HPV) test as cervical screening tools: can we rely on HPV test alone as a screening method? An 11-year retrospective experience at a single institution. J Pathol Transl Med. 2020;54(1):112–118. doi:10.4132/jptm.2019.11.29
  • Ogilvie GS, van Niekerk D, Krajden M, et al. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV FOCAL randomized clinical trial. Obstetrical Gynecol Surv. 2018;73(11):632–634. doi:10.1097/OGX.0000000000000608
  • Nelson EJ, Maynard BR, Loux T, Fatla J, Gordon R, Arnold LD. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex Transm Infect. 2017;93(1):56–61. doi:10.1136/sextrans-2016-052609
  • Madzima TR, Rn MV, Ccfp AL Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women; 2017:5.
  • Asare M, Abah E, Obiri-Yeboah D, Lowenstein L, Lanning B. HPV self-sampling for cervical cancer screening among women living with HIV in low- and middle-income countries: what do we know and what can be done? Healthcare. 2022;10(7):1270. doi:10.3390/healthcare10071270
  • Cómbita AL, Gheit T, González P, et al. Comparison between urine and cervical samples for HPV DNA detection and typing in young women in Colombia. Cancer Prev Res. 2016;9(9):766–771. doi:10.1158/1940-6207.CAPR-16-0038
  • Kuriakose S, Sabeena S, Binesh D, et al. Diagnostic accuracy of self‐collected vaginal samples for HPV DNAdetection in women from South India. Int J Gynecol Obstet. 2020;149(2):219–224. doi:10.1002/ijgo.13116
  • Asciutto KC, Ernstson A, Forslund O, Borgfeldt C. Self-sampling with HPV mRNA analyses from vagina and urine compared with cervical samples. J Clin Virol. 2018;101:69–73. doi:10.1016/j.jcv.2018.02.002
  • Aimagambetova G, Atageldiyeva K, Marat A, et al. Comparison of diagnostic accuracy and acceptability of self-sampling devices for human Papillomavirus detection: a systematic review. Prevent Med Rep. 2024;38:102590. doi:10.1016/j.pmedr.2024.102590
  • DrS J, Saini DS. A Comparison of 3 ways of conventional pap smear, liquid- based cytology and colposcopy vs cervical biopsy for early diagnosis of premalignant lesions or cervical cancer in women with abnormal conventional pap test. Int J Clin Obstet Gynaecol. 2020;4(3):68–71. doi:10.33545/gynae.2020.v4.i3b.576
  • Nkwabong E, Laure Bessi Badjan I, Sando Z. Pap smear accuracy for the diagnosis of cervical precancerous lesions. Trop Doct. 2019;49(1):34–39. doi:10.1177/0049475518798532
  • Murchland AR, Gottschlich A, Bevilacqua K, et al. HPV self-sampling acceptability in rural and indigenous communities in Guatemala: a cross-sectional study. BMJ Open. 2019;9(10):e029158. doi:10.1136/bmjopen-2019-029158
  • Léniz J, Barriga MI, Lagos M, Ibáñez C, Puschel K, Ferreccio C. HPV vaginal self-sampling among women non-adherent to Papanicolaou screening in Chile. Salud pública Méx. 2013;55(2):162–169. doi:10.1590/S0036-36342013000200007
  • Agorastos T, Chatzistamatiou K, Tsertanidou A, et al. Implementation of HPV-based cervical cancer screening combined with self-sampling using a midwifery network across rural Greece: the GRECOSELF study. Cancer Prev Res. 2019;12(10):701–710. doi:10.1158/1940-6207.CAPR-19-0192
  • Malone C, Barnabas RV, Buist DSM, Tiro JA, Winer RL. Cost-effectiveness studies of HPV self-sampling: a systematic review. Preventive Med. 2020;132:105953. doi:10.1016/j.ypmed.2019.105953
  • Surriabre P, Allende G, Prado M, et al. Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in Bolivia. BMC Women’s Health. 2017;17(1):135. doi:10.1186/s12905-017-0490-z
  • Aftab Hussain Talpur M, Napiah M, Ahmed Chandio I, Ahmed Qureshi T. A comprehensive evaluation of basic health facilities according to local standards and demographic features of Umarkot Sub-region, Pakistan. RJASET. 2014;7(22):4754–4762. doi:10.19026/rjaset.7.862
  • Saunders B, Sim J, Kingstone T, et al. Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018;52(4):1893–1907. doi:10.1007/s11135-017-0574-8
  • Vasileiou K, Barnett J, Thorpe S, Young T. Characterising and justifying sample size sufficiency in interview-based studies: systematic analysis of qualitative health research over a 15-year period. BMC Med Res Methodol. 2018;18(1):148. doi:10.1186/s12874-018-0594-7
  • Lindgren BM, Lundman B, Graneheim UH. Abstraction and interpretation during the qualitative content analysis process. Int J Nurs Stud. 2020;108:103632. doi:10.1016/j.ijnurstu.2020.103632
  • Colorafi KJ, Evans B. Qualitative descriptive methods in health science research. HERD. 2016;9(4):16–25. doi:10.1177/1937586715614171
  • Azungah T. Qualitative research: deductive and inductive approaches to data analysis. QRJ. 2018;18(4):383–400. doi:10.1108/QRJ-D-18-00035
  • Bogani G, Sopracordevole F, Ciavattini A, et al. Duration of human papillomavirus persistence and its relationship with recurrent cervical dysplasia. Eur J Cancer Prev. 2023;32(6):525–532. doi:10.1097/CEJ.0000000000000822
  • Balasubramaniam G, Gaidhani RH, Khan A, Saoba S, Mahantshetty U, Maheshwari A. Survival rate of cervical cancer from a study conducted in India. IJMS. 2020;73:203–211. doi:10.25259/IJMS_140_2020
  • Jentschke M, Lehmann R, Drews N, Hansel A, Schmitz M, Hillemanns P. Psychological distress in cervical cancer screening: results from a German online survey. Arch Gynecol Obstet. 2020;302(3):699–705. doi:10.1007/s00404-020-05661-9
  • Akinyemiju TF, McDonald JA, Lantz PM. Health care access dimensions and cervical cancer screening in South Africa: analysis of the world health survey. BMC Public Health. 2015;15(1):382. doi:10.1186/s12889-015-1686-5
  • Yeo C, Fang H, Thilagamangai KSSL, Shorey S, Shorey S. Factors affecting Pap smear uptake in a maternity hospital: a descriptive cross-sectional study. J Adv Nurs. 2018;74(11):2533–2543. doi:10.1111/jan.13769
  • Grigore M, Popovici R, Pristavu A, Grigore AM, Matei M, Gafitanu D. Perception and use of Pap smear screening among rural and urban women in Romania. European Journal of Public Health. 2017;27(6):1084–1088. doi:10.1093/eurpub/ckx112
  • Yanikkerem E, Özdemir M, Bingol H, Tatar A, Karadeniz G. Women’s attitudes and expectations regarding gynaecological examination. Midwifery. 2009;25(5):500–508. doi:10.1016/j.midw.2007.08.006
  • Kabalika C, Mulenga D, Mazaba ML, Siziya, PhD S. Acceptance of cervical cancer screening and its correlates among women of a Peri-Urban high-density residential area in Ndola, Zambia. Int J MCH AIDS. 2018;7(1):17–27. doi:10.21106/ijma.223
  • Morgan K, Azzani M, Khaing SL, Wong YL, Su TT. Acceptability of women self-sampling versus clinician-collected samples for HPV DNA testing: a systematic review. J Low Genit Tract Dis. 2019;23(3):193–199. doi:10.1097/LGT.0000000000000476
  • Vega Crespo B, Neira VA, J OS, et al. Evaluation of urine and vaginal self-sampling versus clinician-based sampling for cervical cancer screening: a field comparison of the acceptability of three sampling tests in a rural community of Cuenca, Ecuador. Healthcare. 2022;10(9):1614. doi:10.3390/healthcare10091614
  • Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health. 2019;4(3):e001351. doi:10.1136/bmjgh-2018-001351
  • Skroumpelos A, Agorastos T, Constantinidis T, Chatzistamatiou K, Kyriopoulos J. Economic evaluation of HPV DNA test as primary screening method for cervical cancer: A health policy discussion in Greece. PLoS One. 2019. Vol. 14. (12). e0226335.
  • Bhatla N, Singhal S. Primary HPV screening for cervical cancer. Best Pract Res Clin Obstet Gynaecol. 2020;65:98–108. doi:10.1016/j.bpobgyn.2020.02.008
  • Shin HY, Lee B, Hwang SH, et al. Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling. J Gynecol Oncol. 2019;30(5):e76. doi:10.3802/jgo.2019.30.e76
  • Rosenbaum AJ, Gage JC, Alfaro KM, et al. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador. Int J Gynecol Obstet. 2014;126(2):156–160. doi:10.1016/j.ijgo.2014.02.026
  • Dutton T, Marjoram J, Burgess S, et al. Uptake and acceptability of human papillomavirus self-sampling in rural and remote aboriginal communities: evaluation of a nurse-led community engagement model. BMC Health Serv Res. 2020;20(1):398. doi:10.1186/s12913-020-05214-5
  • Sy AU, Hernandez BY, Tareg A, Reichhardt M, Buenconsejo-Lum L. Acceptability and feasibility of a community based participatory research project comparing cytology and urine HPV DNA testing for cervical cancer screening in Yap, Federated States of Micronesia. Cancer Epidemiol. 2017;50:283–288. doi:10.1016/j.canep.2017.07.008
  • Jeronimo J, Perkins RB, Scalici J, Pierce JY. Should self-sampling be an option for women in the United States? J Low Genit Tract Dis. 2019;23(1):54–57. doi:10.1097/LGT.0000000000000453
  • Ørnskov D, Jochumsen K, Steiner PH, Grunnet IM, Lykkebo AW, Waldstrøm M. Clinical performance and acceptability of self-collected vaginal and urine samples compared with clinician-taken cervical samples for HPV testing among women referred for colposcopy. A cross-sectional study. BMJ Open. 2021;11(3):e041512. doi:10.1136/bmjopen-2020-041512
  • Ruddies F, Gizaw M, Teka B, et al. Cervical cancer screening in rural Ethiopia: a cross- sectional knowledge, attitude and practice study. BMC Cancer. 2020;20(1):563. doi:10.1186/s12885-020-07060-4
  • Saei Ghare Naz M, Kariman N, Ebadi A, Ozgoli G, Ghasemi V, Rashidi Fakari F. Educational interventions for cervical cancer screening behavior of women: a systematic review. Asian Pac J Cancer Prev. 2018;19(4):1.
  • Austad K, Chary A, Xocop SM, et al. Barriers to cervical cancer screening and the cervical cancer care continuum in rural Guatemala: a mixed-method analysis. JGO. 2018;4(4):1–10. doi:10.1200/JGO.17.00228
  • Eperon I, Vassilakos P, Navarria I, et al. Randomized comparison of vaginal self-sampling by standard vs. dry swabs for Human papillomavirus testing. BMC Cancer. 2013;13(1):353. doi:10.1186/1471-2407-13-353